<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02855554</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00035552</org_study_id>
    <nct_id>NCT02855554</nct_id>
  </id_info>
  <brief_title>Quantitative Cardiac Parametric Mapping (Myomapping)</brief_title>
  <official_title>Novel Magnetic Resonance Imaging Techniques for Quantitative Cardiac Parametric Mapping</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <brief_summary>
    <textblock>
      The overall goal of this project is to evaluate the clinical potential of fast quantitative&#xD;
      myocardial tissue characterization using recently emerged Cardiac Magnetic Resonance Imaging&#xD;
      (CMR) techniques to aid the diagnosis, treatment, and follow up of patients with myocardial&#xD;
      diseases, such as ischemic heart disease, cardiomyopathies, and myocarditis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 20, 2014</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical value of fast T1, T2, and T2* mapping of the left ventricle for the assessment of necrosis/scar, edema, and possible intramyocardial hemorrhage in patients with heart disease.</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Cardiomyopathy, Myocarditis, Ischemic Heart Disease</condition>
  <arm_group>
    <arm_group_label>Additional 5 minute research MR scan of heart.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The purpose of this is to evaluate new, faster MR scans</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiac Magnetic Resonance (CMR) imaging techniques</intervention_name>
    <description>Evaluation of clinical potential of fast quantitative myocardial tissue characterization using recently emerged CMRI techniques to aid the diagnosis, treatment, and follow up of patients with myocardial diseases.</description>
    <arm_group_label>Additional 5 minute research MR scan of heart.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject must be 18-90 years of age.&#xD;
&#xD;
          -  Subject must be previously diagnosed with or suspected to have one of the following&#xD;
             conditions.&#xD;
&#xD;
          -  Myocardial ischemia or infarction (group 1)&#xD;
&#xD;
          -  Hypertrophic cardiomyopathy (group 2)&#xD;
&#xD;
          -  Infiltrative cardiomyopathy (group 3)&#xD;
&#xD;
          -  Myocarditis (group 4)&#xD;
&#xD;
          -  Subject must have been referred for a clinically indicated CMR.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has any implanted device or condition in which an MR scan would be&#xD;
             contraindicated.&#xD;
&#xD;
          -  Subject has an acute psychiatric disorder or is cognitively impaired.&#xD;
&#xD;
          -  Subject is using or is dependent on substances of abuse.&#xD;
&#xD;
          -  Subject is unwilling to comply with the requirements of the protocol.&#xD;
&#xD;
          -  Subject has previously entered this study.&#xD;
&#xD;
          -  Subject has an allergy against MRI contrast agents.&#xD;
&#xD;
          -  Subject is in acute unstable condition.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph U. Schoepf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frank Beylotte, MS</last_name>
    <phone>843-792-1930</phone>
    <email>beylott@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tyler Leonard, BS</last_name>
    <phone>843-876-3185</phone>
    <email>leonarty@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Martinez, MS</last_name>
      <phone>843-876-7148</phone>
      <email>martjohn@musc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Hunter Gray, BS</last_name>
      <phone>843-876-4922</phone>
      <email>grayhu@musc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Joseph U. Schoepf, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>July 28, 2016</study_first_submitted>
  <study_first_submitted_qc>August 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2016</study_first_posted>
  <last_update_submitted>April 16, 2021</last_update_submitted>
  <last_update_submitted_qc>April 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>U. Joseph Schoepf, MD</investigator_full_name>
    <investigator_title>Director, Division of Cardiovascular Imaging</investigator_title>
  </responsible_party>
  <keyword>myocardial tissue characterization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocarditis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

